抗合成酶综合征中抗PL12自身抗体的共享分子谱
该研究从常规肌炎免疫印迹中识别出10例抗PL12自身抗体阳性患者(7女3男,平均年龄65岁),全部有肺部疾病,2例合并肌炎。采用质谱测序分析纯化的血清抗PL12 IgG可变区亚家族使用和体细胞高频突变,发现寡克隆库共享IGHV3-23重链及IGKV3-20、IGKV1-27轻链表达,且无关患者间共享可能位于抗原交互区的IgV体细胞高频突变。作者认为这些独特分子特征有潜力成为优于常规免疫检测简单读出的生物标志物。
要点
- 10例抗PL12阳性患者全部有肺部疾病,2例合并肌炎。
- 质谱测序显示抗PL12 IgG为寡克隆库,共享IGHV3-23重链表达。
- 轻链共享IGKV3-20和IGKV1-27编码序列表达。
核心结论
- 不同患者的抗PL12自身抗体显示高度趋同的序列和可变区组成。
- 个体间相似性揭示抗原驱动克隆选择中针对PL12特定推测免疫优势表位的进化过程。
- 这些独特抗PL12自身抗体分子特征有潜力成为与常规免疫检测简单读出相比有价值的生物标志物。
研究设计与样本
- 从常规肌炎免疫印迹中识别抗PL12自身抗体患者,共10例,7女3男,平均年龄65岁。
- 采用常规对流免疫电泳从特异性抗PL12沉淀素中纯化血清抗PL12 IgG自身抗体。
- 免疫球蛋白重链和轻链经SDS-PAGE分离、酶切后,通过质谱测序分析免疫球蛋白可变区亚家族使用和体细胞高频突变。
主要发现
- 全部10例患者均有肺部疾病,其中2例合并肌炎。
- 沉淀性抗PL12 IgG的质谱测序显示寡克隆库,共享表达IGHV3-23编码重链以及IGKV3-20和IGKV1-27编码轻链。
- 在无关患者间观察到重链和轻链共享的IgV体细胞高频突变,位于可能抗原交互区域。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Anti-PL12 autoantibodies are targeted against alanyl-tRNA synthetase, a cytosolic enzyme which plays a vital role in protein synthesis. Clinically, such antibodies are strongly associated with interstitial lung disease and confer a poor prognosis. To better understand their molecular composition, anti-PL12 immunoglobulin variable region subfamily expression and their mutational signatures were analysed by mass spectrometry (MS)-based proteomics to provide insights into personalized molecular diagnosis. METHODS: Patients with anti-PL12 autoantibodies were identified from routine myositis immunoblots. Serum anti-PL12 IgG autoantibodies were then purified from specific anti-PL12 precipitins using conventional counter-immunoelectrophoresis. Immunoglobulin (Ig) heavy and light-chains were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), digested by enzymes and profiled by MS sequencing for immunoglobulin variable region (IgV) subfamily usage and somatic hypermutation analysis. RESULTS: Ten patients were identified; seven females and three males with an average age of 65 years. All had lung disease, while two had concurrent myositis. MS sequencing of precipitating anti-PL12 IgGs revealed an oligoclonal repertoire with shared expression of IGHV3-23-encoded heavy chain and IGKV3-20- and IGKV1-27-encoded light chains. Furthermore, shared IgV somatic hypermutations were observed across unrelated patients in both heavy and light chain, in regions likely to be antigen interacting. CONCLUSION: Anti-PL12 autoantibodies among different patients show highly convergent sequences and variable region composition. The inter-individual similarity reveals the evolutionary process towards specific, presumably immuno-dominant, epitopes on PL12 during antigen-driven clonal selection. These unique anti-PL12 autoantibody molecular signatures have the potential to be valuable biomarkers when compared with the simple readout of conventional immunoassays.
引用
- Ali SB, Troelnikov A, Amour B, et al. Shared molecular profiles of anti-PL12 autoantibodies in anti-synthetase syndrome. Rheumatology (Oxford). 2025. PMID: 40632596. doi:10.1093/rheumatology/keaf357
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。